Perceptions of who lives the mental disorder and the abuse of alcohol and other drugs
Main Article Content
Abstract
Objective: To describe the feelings and symptoms of people in mental distress who lives with comorbidities between the use of alcohol and other drugs and severe and persistent mental disorder. Methodology: descriptive and qualitative study conducted in six rehab for substance abuse and a Psychosocial Care Center. The data has been collected via individual interview depth and application of therapeutic communication with 31 patients. The interviews were fully transcribed and raisins for the content analysis process, thematic modality. Results: The results were made up of units of perceptions of situations before the falling ill, its articulated beginning with motivation and drug use, as well as symptoms and concomitant feelings the disorder substance use and/or mental disorder. Final remarks: The relationship of drug use with the mental disorder at sometimes does not make clear, but it is exists, as evidenced in our study by speech of the interviewees, to the associate the use and abuse of drugs in the attempt to alleviate or deal with unpleasant affective states such as boredom, depression, anxiety and loneliness.
Article Details
How to Cite
LUCCHESE, Roselma et al.
Perceptions of who lives the mental disorder and the abuse of alcohol and other drugs.
Medical Research Archives, [S.l.], v. 2, n. 3, oct. 2015.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/327>. Date accessed: 25 nov. 2024.
Keywords
Disorders related to substance use; Mental Disorders; Comorbidities; Mental Health
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Stein DJ, Phillips KA, Bolton D, Fulford KW, Sadler JZ, Kendler KS. What is a Mental Psychiatric Disorder? From DSM-IV to DSM-V. Psychol Med, 2010; v. 11,n. 40, pp. 1759-1765.
2. Turkington A, Mulholland CC, Rushe T, Anderson R, McCaul R, Barrett SL. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry, 2009; n.195, pp. 242–248.
3. Schuckit MA, Smith TL, Kalmijn J. Relationships Among Independent Major Depressions, Alcohol Use, and Other Substance Use and Related Problems Over 30 Years in 397 Families. J Stud Alcohol Drugs, 2013; v.74, pp. 271-279.
4. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis. Rev. Arch Gen Psychiatry, 2011; v.68, pp. 555-561.
5. Latt N, Jurd S, Tennant C, Lewis J, Macken L, Joseph A, Grochulski A, Long L. Changing Patterns Alcohol and Substance Use by Patients with psychosis Presenting to an Emergency Department. Rev. Australasian Psychiatry, 2011; Aug; 19(4):354-359.
6. Harrington M, Robinson J, Bolton SL, Sareen J, Bolton J.. A Longitudinal Study of Risk Factors for Incident Drug Use in Adults: Findings From a Representative Sample of the Us Population. The Canadian Journal of Psychiatry, 2011; Nov; 56(11):686-695.
7. Zammit S, Moore TH, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Glyn Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Rev. The British Journal of Psychiatry, 2008; v.193, pp. 357–363.
8. Fraser S, Hides L, Philips L, Proctor D, Dan I, Lubman DI. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people. Rev.Schizophrenia Research, 2012; v. 136, pp. 110-115.
9. Niemi-Phynttari JA, Dsocsc RS, Putkonen H, Wahlbeck K, Pirkola DP. Substance-Induced Psychoses Converting Into Schizophrenia: A Register-Based Study of 18,478 Finnish Inpatient Cases. J Clin Psychiatry, 2013; v.74, pp. 94-99.
10. Chakraborty R, Chatterjee A, Chaudhury S. Impact of Substance Use Disorder on Presentation and Short-Term Course of Schizophrenia. Psychiatry Journal, , Epub 2014; April 2.
11. Viola TW, Tractenberg SG, Silva LEW, Rosa CSO, Pezzi JC, Oliveira RG. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Drug and Alcohol Dependence, 2014; v. 144, pp. 153-159.
12. United Nations Office on Drugs and Crime (UNODC), World Drug Report. June 2014 [acesso em 2014 dez 7] Disponível em: http://www.unodc.org/documents/lpo-brazil/noticias/2014/06/World_Drug_Report_2014_web_embargoed.pdf.
13. Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Sherliker P, Kong X, Whitlock G, Boreham J, Brennan P, Peto R. Alcohol and mortality in Russia: prospective observational study of 151000 adults. The Lancet, 2014: v 383, pp 1465-1473.
14. Chadwick B, Miller ML, Hurd YL. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. Frontiers in Psychiatry, 2013, october v. 4(129).
15. Kolliakou A, Joseph C, Ismail K, Atakan ZM, Murray RM. Why do patients with psychosis use cannabis and are they ready to change their use? International Journal of Developmental Neuroscience, 2011; p 335–346.
16. Cruz M, Bertoni N, Bastos FI, Burnett C, Gooch J, Fischer B. Comparing key characteristics of young adult crack users in and out-of-treatment in Rio de Janeiro, Brazil. Rev. Substance Abuse Treatment, Prevention, and Policy, 2014; v.9 (2).
17. Wagner KD, Ritt-Olson A, Chou CP, Pokhrel P, Duan L, Baezconde-Garbanati L, et al. Associations Between Family Structure, Family Functioning, and Substance Use Among Hispanic/Latino Adolescents. Psicol Addict Behav, 2011; v. 24(1), pp 98–108.
18. Conus P, Cotton S, Schimmelmann BG, McGorry PD, Lambert M. Pretreatment and Outcome Correlates of Sexual and Physical Trauma in an Epidemiological Cohort of First-Episode Psychosis Patients. Rev. Schizophrenia Bulletin, 2010; v. 36(6), pp. 1105–1114.
19. Koskinen J, Lohonen J, Koponen H, Matti Isohanni M, Miettunen J. Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis. Rev. Schizophrenia Bulletin, 2010; v. 36(6), pp. 1115–1130.
20. Volkow ND. Substance Use Disorders in Schizophrenia: Clinical Implications of Comorbidity. Rev. Schizophrenia Bulletin, 2009; v. 35 (3), pp. 469-472.
21. Gururajan A, Manning EE, Klug M, Buuse MVD. Drugs of abuse and increased risk of psychosis development. Australian & New Zealand Journal of Psychiatry, 2012; v. 46(12), 1020-1035.
22. Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, Antal P, Szilagyi A, Sasvari-Szekely M, Barta C. Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence. Rev. Association Study of Heroin Dependence, 2013; Jun V. 8(6).
23. Pettersen H, Ruud T, Ravndal E, Landheim A. Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness. International Journal of Qualitative Studies on Health and Well-Being, 2013; Dec, V. 8(10).
24. Khantzian EJ. The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications Harvard. Rev. Review of Psychiatry, 1997; v. 4(5), pp. 231-244.
25. Bizzarri JV, Rucci P, Sbrana A, Miniati M, Raimondi F, Ravani L, Massei GJ, Milani F, Milianti M, Massei G, Gonnelli C, Cassano GB. Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry research, 2009; V. 165, pp.88 -95.
26. Asher CJ, Gask L. Reasons for illicit drug use in people with schizophrenia: Qualitative study. BMC Psychiatry, 2010; Nov V. 10(94), pp.1-15.
27. Starcevic V. Dysphoric About Dysphoria: Towards a Greater Conceptual Clarity of the Term. Australasian Psychiatry, 2007; V. 15 (1).
28. Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophrenia Research, 2014; V. 156, pp. 211–216.
29. Andreasson S, Allebeck P, Engstrom A, Rydberg US. Cannabis and schizophrenia. A longitudinal study of swedish conscripts. Rev Lancet, 1987; V.26, pp 1483-1486.
30. Zubaran C, Foresti K, Thorell MR, Franceschini PR. Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil. Rev Assoc Med Bras, 2013; V. 59, pp. 360-367.
31. Chaves TV, Sanchez ZM, Ribeiro LA, Nappo SA. Fissura por crack: comportamentos e estratégias de controle de usuários e ex-usuários. Rev. Saúde Pública, 2011; Dec V. 45(6), pp.1168-1175.
32. Patrick ME, Wightma P, Schulenberg JE. Socioeconomic Status and Substance Use Among Young Adults: A Comparison Across Constructs and Drugs. Journal of Studies on Alcohol and Drugs, 2012; pp 772-782.
33. Cheng T, Wood E, Kerr PNT, Debeck K. Increases and decreases in drug use attributed to housing status among street-involved youth in a Canadian setting. Rev. Harm Reduction Journal, 2014: V. 11(12), pp 1-6.
2. Turkington A, Mulholland CC, Rushe T, Anderson R, McCaul R, Barrett SL. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry, 2009; n.195, pp. 242–248.
3. Schuckit MA, Smith TL, Kalmijn J. Relationships Among Independent Major Depressions, Alcohol Use, and Other Substance Use and Related Problems Over 30 Years in 397 Families. J Stud Alcohol Drugs, 2013; v.74, pp. 271-279.
4. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis. Rev. Arch Gen Psychiatry, 2011; v.68, pp. 555-561.
5. Latt N, Jurd S, Tennant C, Lewis J, Macken L, Joseph A, Grochulski A, Long L. Changing Patterns Alcohol and Substance Use by Patients with psychosis Presenting to an Emergency Department. Rev. Australasian Psychiatry, 2011; Aug; 19(4):354-359.
6. Harrington M, Robinson J, Bolton SL, Sareen J, Bolton J.. A Longitudinal Study of Risk Factors for Incident Drug Use in Adults: Findings From a Representative Sample of the Us Population. The Canadian Journal of Psychiatry, 2011; Nov; 56(11):686-695.
7. Zammit S, Moore TH, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Glyn Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Rev. The British Journal of Psychiatry, 2008; v.193, pp. 357–363.
8. Fraser S, Hides L, Philips L, Proctor D, Dan I, Lubman DI. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people. Rev.Schizophrenia Research, 2012; v. 136, pp. 110-115.
9. Niemi-Phynttari JA, Dsocsc RS, Putkonen H, Wahlbeck K, Pirkola DP. Substance-Induced Psychoses Converting Into Schizophrenia: A Register-Based Study of 18,478 Finnish Inpatient Cases. J Clin Psychiatry, 2013; v.74, pp. 94-99.
10. Chakraborty R, Chatterjee A, Chaudhury S. Impact of Substance Use Disorder on Presentation and Short-Term Course of Schizophrenia. Psychiatry Journal, , Epub 2014; April 2.
11. Viola TW, Tractenberg SG, Silva LEW, Rosa CSO, Pezzi JC, Oliveira RG. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Drug and Alcohol Dependence, 2014; v. 144, pp. 153-159.
12. United Nations Office on Drugs and Crime (UNODC), World Drug Report. June 2014 [acesso em 2014 dez 7] Disponível em: http://www.unodc.org/documents/lpo-brazil/noticias/2014/06/World_Drug_Report_2014_web_embargoed.pdf.
13. Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Sherliker P, Kong X, Whitlock G, Boreham J, Brennan P, Peto R. Alcohol and mortality in Russia: prospective observational study of 151000 adults. The Lancet, 2014: v 383, pp 1465-1473.
14. Chadwick B, Miller ML, Hurd YL. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. Frontiers in Psychiatry, 2013, october v. 4(129).
15. Kolliakou A, Joseph C, Ismail K, Atakan ZM, Murray RM. Why do patients with psychosis use cannabis and are they ready to change their use? International Journal of Developmental Neuroscience, 2011; p 335–346.
16. Cruz M, Bertoni N, Bastos FI, Burnett C, Gooch J, Fischer B. Comparing key characteristics of young adult crack users in and out-of-treatment in Rio de Janeiro, Brazil. Rev. Substance Abuse Treatment, Prevention, and Policy, 2014; v.9 (2).
17. Wagner KD, Ritt-Olson A, Chou CP, Pokhrel P, Duan L, Baezconde-Garbanati L, et al. Associations Between Family Structure, Family Functioning, and Substance Use Among Hispanic/Latino Adolescents. Psicol Addict Behav, 2011; v. 24(1), pp 98–108.
18. Conus P, Cotton S, Schimmelmann BG, McGorry PD, Lambert M. Pretreatment and Outcome Correlates of Sexual and Physical Trauma in an Epidemiological Cohort of First-Episode Psychosis Patients. Rev. Schizophrenia Bulletin, 2010; v. 36(6), pp. 1105–1114.
19. Koskinen J, Lohonen J, Koponen H, Matti Isohanni M, Miettunen J. Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis. Rev. Schizophrenia Bulletin, 2010; v. 36(6), pp. 1115–1130.
20. Volkow ND. Substance Use Disorders in Schizophrenia: Clinical Implications of Comorbidity. Rev. Schizophrenia Bulletin, 2009; v. 35 (3), pp. 469-472.
21. Gururajan A, Manning EE, Klug M, Buuse MVD. Drugs of abuse and increased risk of psychosis development. Australian & New Zealand Journal of Psychiatry, 2012; v. 46(12), 1020-1035.
22. Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, Antal P, Szilagyi A, Sasvari-Szekely M, Barta C. Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence. Rev. Association Study of Heroin Dependence, 2013; Jun V. 8(6).
23. Pettersen H, Ruud T, Ravndal E, Landheim A. Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness. International Journal of Qualitative Studies on Health and Well-Being, 2013; Dec, V. 8(10).
24. Khantzian EJ. The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications Harvard. Rev. Review of Psychiatry, 1997; v. 4(5), pp. 231-244.
25. Bizzarri JV, Rucci P, Sbrana A, Miniati M, Raimondi F, Ravani L, Massei GJ, Milani F, Milianti M, Massei G, Gonnelli C, Cassano GB. Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry research, 2009; V. 165, pp.88 -95.
26. Asher CJ, Gask L. Reasons for illicit drug use in people with schizophrenia: Qualitative study. BMC Psychiatry, 2010; Nov V. 10(94), pp.1-15.
27. Starcevic V. Dysphoric About Dysphoria: Towards a Greater Conceptual Clarity of the Term. Australasian Psychiatry, 2007; V. 15 (1).
28. Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophrenia Research, 2014; V. 156, pp. 211–216.
29. Andreasson S, Allebeck P, Engstrom A, Rydberg US. Cannabis and schizophrenia. A longitudinal study of swedish conscripts. Rev Lancet, 1987; V.26, pp 1483-1486.
30. Zubaran C, Foresti K, Thorell MR, Franceschini PR. Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil. Rev Assoc Med Bras, 2013; V. 59, pp. 360-367.
31. Chaves TV, Sanchez ZM, Ribeiro LA, Nappo SA. Fissura por crack: comportamentos e estratégias de controle de usuários e ex-usuários. Rev. Saúde Pública, 2011; Dec V. 45(6), pp.1168-1175.
32. Patrick ME, Wightma P, Schulenberg JE. Socioeconomic Status and Substance Use Among Young Adults: A Comparison Across Constructs and Drugs. Journal of Studies on Alcohol and Drugs, 2012; pp 772-782.
33. Cheng T, Wood E, Kerr PNT, Debeck K. Increases and decreases in drug use attributed to housing status among street-involved youth in a Canadian setting. Rev. Harm Reduction Journal, 2014: V. 11(12), pp 1-6.